These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30084297)

  • 21. The optimal pre-post allocation for randomized clinical trials.
    Ma S; Wang T
    BMC Med Res Methodol; 2023 Mar; 23(1):72. PubMed ID: 36978004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of covariance in parallel-group clinical trials with pretreatment baselines.
    Crager MR
    Biometrics; 1987 Dec; 43(4):895-901. PubMed ID: 3427174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of continuous outcomes: Using pseudo IPD created from aggregate data to adjust for baseline imbalance and assess treatment-by-baseline modification.
    Papadimitropoulou K; Stijnen T; Riley RD; Dekkers OM; le Cessie S
    Res Synth Methods; 2020 Nov; 11(6):780-794. PubMed ID: 32643264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?
    Walters SJ; Jacques RM; Dos Anjos Henriques-Cadby IB; Candlish J; Totton N; Xian MTS
    Trials; 2019 Sep; 20(1):566. PubMed ID: 31519202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of randomised trials with a continuous outcome according to baseline imbalance and availability of individual participant data.
    Riley RD; Kauser I; Bland M; Thijs L; Staessen JA; Wang J; Gueyffier F; Deeks JJ
    Stat Med; 2013 Jul; 32(16):2747-66. PubMed ID: 23303608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empirical comparison of four baseline covariate adjustment methods in analysis of continuous outcomes in randomized controlled trials.
    Zhang S; Paul J; Nantha-Aree M; Buckley N; Shahzad U; Cheng J; DeBeer J; Winemaker M; Wismer D; Punthakee D; Avram V; Thabane L
    Clin Epidemiol; 2014; 6():227-35. PubMed ID: 25053894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline correction in a two-way randomized blocks design.
    Overall JE; Magee KN
    J Biopharm Stat; 1992; 2(2):205-17. PubMed ID: 1300214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leveraging prognostic baseline variables to gain precision in randomized trials.
    Colantuoni E; Rosenblum M
    Stat Med; 2015 Aug; 34(18):2602-17. PubMed ID: 25872751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statistical power for analyses of changes in randomized controlled trials.
    Tu YK; Blance A; Clerehugh V; Gilthorpe MS
    J Dent Res; 2005 Mar; 84(3):283-7. PubMed ID: 15723872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
    Stampf S; Graf E; Schmoor C; Schumacher M
    Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline corrections in experimental and quasi-experimental clinical trials.
    Overall JE; Ashby B
    Neuropsychopharmacology; 1991 Jun; 4(4):273-81. PubMed ID: 1867736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covariate adjustment and estimation of mean response in randomised trials.
    Bartlett JW
    Pharm Stat; 2018 Sep; 17(5):648-666. PubMed ID: 29998483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-centered ANCOVA: Resolving contradictory results from Lord's paradox with implications for reducing bias in longitudinal analyses.
    Lin H; Larzelere RE
    J Adolesc; 2020 Dec; 85():135-147. PubMed ID: 33242670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the mixed model for repeated measures to robustly increase precision in randomized trials.
    Wang B; Du Y
    Int J Biostat; 2023 Nov; ():. PubMed ID: 38016707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact Evaluation Using Analysis of Covariance With Error-Prone Covariates That Violate Surrogacy.
    Lockwood JR; McCaffrey DF
    Eval Rev; 2019 Dec; 43(6):335-369. PubMed ID: 31578089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simple, efficient estimators of treatment effects in randomized trials using generalized linear models to leverage baseline variables.
    Rosenblum M; van der Laan MJ
    Int J Biostat; 2010 Apr; 6(1):Article 13. PubMed ID: 20628636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empirical likelihood inference in randomized clinical trials.
    Zhang B
    Stat Methods Med Res; 2018 Dec; 27(12):3770-3784. PubMed ID: 28679341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On efficiency of constrained longitudinal data analysis versus longitudinal analysis of covariance.
    Lu K
    Biometrics; 2010 Sep; 66(3):891-6. PubMed ID: 19764951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Covariate imbalance and conditional size: dependence on model-based adjustments.
    Maxwell SE
    Stat Med; 1993 Jan; 12(2):101-9. PubMed ID: 8446806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.